8 of 10 ECCO members trust Celltrion’s Remsima

At the 11^th European Crohn’s and Colitis Organization(ECCO) held in Amsterdam, Netherlands from 16^th to 19^th of March, a survey was announced 8 of 10 ECCO members trust biosimilar antibodies like Remsima.

According to the survey, the credibility on biosimilars was only 39% in 2013, but was increased to 80% in 2015, relied by 8 of 10 respondents to the survey. Moreover, only would 6% of the res...